Human Bcl9-2 Antibody Summary
Met38-Val206
Accession # Q86UU0
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Detection of Human Bcl9‑2 by Western Blot. Western blot shows lysates of A172 human glioblastoma cell line and MCF-7 human breast cancer cell line. PVDF membrane was probed with 1 µg/mL of Human Bcl9-2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF4967) followed by HRP-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # HAF016). A specific band was detected for Bcl9-2 at approximately 190 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
View Larger
Detection of Bcl9-2 by Western Blot BCL9L expression in primary pancreatic tumor tissue and cell lines(A) Box-and-whisker plot showing results from BCL9L mRNA expression analysis by qRT-PCR in tissue samples derived from primary human pancreatic tumors (n = 26 cases), chronic pancreatitis (n = 6 cases) and normal pancreas (n = 13 cases). Expression was normalized to ribosomal protein, large, P0 (RPLP0) mRNA levels. Bars represent median and 2nd and 3rd quartiles (boxes) as well as minimum and maximum values (whiskers). **p ≤ 0.01, ***p ≤ 0.001 (Student's t-test). (B) BCL9L mRNA levels in pancreatic cancer (8988t, IMIM PC1, IMIM PC2, MiaPaca-2, Panc1, S2-007, S2-028) and control (HEK 293) cell lines. (C) Staining of tissue microarrays (TMA) for BCL9L expression using immunohistochemistry. Enhanced expression was seen in PDAC tissues (bottom panels) compared to normal pancreas (upper panels). Staining intensity in PDAC tissues increased with tumor grade (bottom left: G1, bottom middle: G2, bottom right: G3). (D) BCL9L staining intensity of tissue microarrays was quantitatively evaluated and scored in normal and PDAC cases as described in Materials and Methods. Scores significantly increased with the progression to less differentiated PDAC (grade 2 and 3). ***p ≤ 0.001 (Mann-Whitney and Kruskal-Wallis non parametric test) (E) BCL9L protein expression in pancreatic cancer and control (HPNE) cell lines was quantified by western blotting. Detection of alpha -tubulin was used as a loading control. Shown is a representative image of 3 experiments. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/27713160), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Bcl9-2
Bcl9-2 (B-cell lymphoma 9-like protein; also Bcl9L and B9L) is a 200-220 kDa transcriptional regulator that belongs to the Bcl9 family of proteins. It is expressed in multiple tissues, particularly breast, and serves to recruit Pygopus to the Wnt-pathway beta -catenin-TCF complex in the nucleus. Bcl9-2 and Bcl9 are considered evolutionary duplicates of Legless that perform the same task with different regulation. Human Bcl9-2 is 1499 amino acids (aa) in length. It contains two Pro-rich regions (aa 280-493 and 891-1378). There are four potential alternate start sites at Met879, Met1000, Met708 and Met472. The last two start sites are accompanied by a deletion of aa 1241-1286, and a 62 aa substitution for the C-terminal 167 aa, respectively. Over aa 38-206, human Bcl9-2 is 94% aa identical to mouse Bcl9-2. Bcl9-2 has been identified as a phosphoprotein in several human cancer cell lines and mouse liver.
Product Datasheets
Citations for Human Bcl9-2 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
6
Citations: Showing 1 - 6
Filter your results:
Filter by:
-
Targeted Disruption of the BCL9/ beta -Catenin Complex Inhibits Oncogenic Wnt Signaling
Authors: Kohichi Takada, Di Zhu, Gregory H. Bird, Kumar Sukhdeo, Jian-Jun Zhao, Mala Mani et al.
Science Translational Medicine
-
Kinase inhibition profiles as a tool to identify kinases for specific phosphorylation sites
Authors: NA Watson, TN Cartwright, C Lawless, M Cámara-Don, O Sen, K Sako, T Hirota, H Kimura, JMG Higgins
Nat Commun, 2020-04-03;11(1):1684.
Species: Human
Sample Types: Cell Culture Lysates
Applications: ELISA Capture -
Pharmacological inhibition of ?-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells
Authors: M Feng, JQ Jin, L Xia, T Xiao, S Mei, X Wang, X Huang, J Chen, M Liu, C Chen, S Rafi, AX Zhu, YX Feng, D Zhu
Sci Adv, 2019-05-08;5(5):eaau5240.
Species: N/A
Sample Types: Peptides
Applications: Immunoprecipitation -
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models
Authors: J Mieszczane, LM van Tienen, AEK Ibrahim, DJ Winton, M Bienz
Nat Commun, 2019-02-13;10(1):724.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Role of BCL9L in transforming growth factor-beta (TGF-beta )-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer
Authors: Giuseppina Sannino, Nicole Armbruster, Mona Bodenhöfer, Ursula Haerle, Diana Behrens, Malte Buchholz et al.
Oncotarget
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Role of BCL9L in transforming growth factor-beta (TGF-beta )-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer
Authors: Giuseppina Sannino, Nicole Armbruster, Mona Bodenhöfer, Ursula Haerle, Diana Behrens, Malte Buchholz et al.
Oncotarget
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human Bcl9-2 Antibody
There are currently no reviews for this product. Be the first to review Human Bcl9-2 Antibody and earn rewards!
Have you used Human Bcl9-2 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
